For both sides
Interstate commerce and trigger laws
Federal and state law current as of September 2026 — verify with counsel.
Marijuana cannot lawfully cross state lines, even between two legal states, because federal law prohibits it and every state system is built as a closed loop. Oregon (2019), California (2022), and Washington (2023) passed trigger laws letting their governors sign interstate agreements once federal law or Justice Department policy allows it. No trigger has been met, and the April 2026 Schedule III order did not change that.
Key takeaways
- Oregon SB 582 (2019), California SB 1326 (2022), and Washington SB 5069 (signed May 2023) authorise interstate cannabis agreements only after a federal trigger.
- California's law had a fourth, state-level trigger, but on 19 December 2023 the Attorney General concluded interstate agreements would create significant legal risk under the Controlled Substances Act.
- Federal appeals courts are split on whether the dormant Commerce Clause applies to cannabis: the First and Second Circuits say yes, the Ninth Circuit said no on 2 January 2026.
- The Supreme Court declined to take up the question in Jensen v. Maryland Cannabis Administration on 23 February 2026.
- Interstate commerce would likely lower the value of cultivation in high-cost states and raise the value of low-cost producers, brands, and retail in import states.
Why can’t cannabis cross state lines?
Two layers of law stop it.
Federal. Distributing marijuana is a federal offence, and moving it across a state line adds interstate trafficking. The federal enforcement guidance that state programmes grew up under listed stopping diversion to other states as a priority, and states designed their systems around that.
State. Every licensing state requires product sold in its stores to be grown, processed, and tested by its own licensees and recorded in its own track-and-trace system. There is no mechanism to receive an out-of-state package. A licensee who imports or exports risks the licence as well as prosecution.
The result is a set of sealed state markets. Oregon, with ideal growing conditions, cannot sell its surplus to New York. A multi-state operator must build cultivation and manufacturing in each state it serves. That duplication is a large part of why the industry’s economics look the way they do; see MSOs and consolidation.
What are trigger laws?
A trigger law authorises a state’s governor to sign an agreement with another state for cross-border cannabis trade, but only after a specified federal event.
| State | Law | Triggers | Status, September 2026 |
|---|---|---|---|
| Oregon | SB 582 (2019, Oregon Laws chapter 464) | Federal law allows interstate transfer, or the Justice Department issues an opinion or memo allowing or tolerating it | Not triggered |
| California | SB 1326 (2022) | Four alternatives: federal law authorises transfers; federal law bars spending to prevent them; a Justice Department opinion tolerates them; or the California Attorney General opines that agreements pose no significant legal risk to the state | Not triggered. The Attorney General’s 19 December 2023 opinion found significant legal risk |
| Washington | SB 5069 (signed May 2023) | Federal law allows interstate transfer, or a Justice Department opinion or memo allows or tolerates it | Not triggered |
Under all three, an agreement would have to keep product inside the regulated system: tracked, tested to the receiving state’s standards, and taxed. Both states would need a law, so the three West Coast statutes can only pair with each other today, and all three are exporting states with surplus supply.
The California episode matters most. It was the only trigger within a state’s own control. The Department of Cannabis Control asked for the opinion in early 2023, arguing that federal law could not commandeer the state. The Attorney General’s office concluded that state officials could face exposure under the Controlled Substances Act. That closed the only route that did not depend on Washington, D.C.
Did Schedule III change anything?
Not for interstate trade. The 28 April 2026 order moved state-licensed medical marijuana to Schedule III, set up a registration path, and kept import and export under permit. It did not amend any trigger condition, and no Justice Department statement tolerating state-to-state transfers has followed. Adult-use marijuana remains Schedule I. Whether a future federal framework for registered medical operators might allow shipment between registrants is speculation at this point. Current federal status is tracked in rescheduling status and what it changes.
The litigation: does the Constitution already require open borders?
The dormant Commerce Clause bars states from discriminating against out-of-state business unless Congress permits it. Litigants have used it against residency requirements, and the reasoning could in theory reach bans on out-of-state product.
| Case | Court and date | Holding |
|---|---|---|
| Northeast Patients Group v. United Cannabis Patients and Caregivers of Maine | 1st Cir., 17 August 2022 | Maine’s rule that dispensary officers and directors be residents violated the dormant Commerce Clause |
| Variscite NY Four v. New York State Cannabis Control Board | 2d Cir., 12 August 2025 | New York licensing preferences tied to in-state convictions were discriminatory; the clause applies to cannabis |
| Jensen v. Maryland Cannabis Administration | 4th Cir., 2 September 2025 | Maryland’s social-equity criteria did not discriminate, so the court did not decide whether the clause applies. Supreme Court review denied 23 February 2026 |
| Peridot Tree WA v. Washington State Liquor and Cannabis Control Board | 9th Cir., 2 January 2026 | The clause does not protect a market Congress has made illegal; Washington’s residency rule and a Sacramento resident set-aside upheld. A certiorari petition was filed on 10 September 2026 (No. 26-343) and was pending, with a response due 15 October 2026 |
So the answer depends on geography. In the Northeast, residency barriers to ownership are vulnerable. In the West, they stand. No court has ordered a state to accept out-of-state marijuana, and commentators expect little movement without an act of Congress. For buyers, the ownership side of this is covered in ownership caps and residency rules by state.
What interstate commerce would do to business value
Nobody can date it, but a buyer holding an asset for five to ten years should think about direction.
| Asset | Likely effect if borders open | Reason |
|---|---|---|
| Outdoor and greenhouse cultivation in low-cost regions (Oregon, Northern California) | Positive | Access to higher-priced markets |
| Indoor cultivation in high-cost, limited-licence states | Negative | Local wholesale prices converge toward national cost of production |
| Retail in import states | Neutral to positive | Cheaper supply, same local licence scarcity |
| Brands and manufacturers with recognised products | Positive | One production site can serve many states |
| Vertically integrated licences valued for captive supply | Mixed | The cultivation leg loses protection; the retail leg keeps it |
| Testing labs and distributors | Uncertain | Depends on where testing and tax are imposed |
Illustrative arithmetic: if indoor flower wholesales at $2,200 per pound in a limited-licence state and landed cost from an exporting state would be $900 per pound including freight and testing, a local cultivator producing at $1,100 per pound moves from a $1,100 margin to a loss. These prices are invented for illustration. The point is that value built on a closed border is a regulatory asset, and should be underwritten as one. See license value in capped vs uncapped states and how oversupply and price compression affect value.
Practical responses in deals today:
- Do not pay for interstate upside in an exporting state. Treat it as a free option.
- In protected states, shorten the payback period you require on cultivation assets compared with retail.
- For sellers of high-cost cultivation in capped states, the closed border is part of what a buyer is paying for now. That argues against waiting; see selling in an oversupplied market for the opposite case.
Diligence red flags
Any current arrangement that moves plant-touching product across a state line is a licence-threatening and criminal issue, whatever it is called. Watch for shared inventory between sister companies in neighbouring states, “genetics transfers” of clones or tissue culture with no documented lawful source, and out-of-state biomass entering a manufacturing process. Seeds and hemp-derived inputs raise their own questions under the changing hemp definition, covered in hemp vs marijuana: legal distinction for buyers.
This page is educational, not legal advice, and reflects the position as of mid-September 2026.
Frequently asked questions
Can a multi-state operator move product between its own licences in different states?
No. Each state's track-and-trace system only recognises transfers between licences issued by that state, and carrying marijuana across a state line is a federal offence regardless of who owns both ends. Multi-state operators run separate cultivation and manufacturing in every state for that reason, which is why their costs are duplicated.
Did moving medical marijuana to Schedule III allow interstate shipping?
No. The April 2026 order created a federal registration path for state medical licensees and kept import and export under permit, but it did not authorise state-licensed businesses to ship to each other across state lines. State laws still require all product to be grown, made, and sold in-state, and adult-use marijuana remains Schedule I.
Can hemp products cross state lines?
Products that meet the federal definition of hemp can, and the 2018 Farm Bill bars states from blocking transport of lawful hemp through their territory. The definition narrows sharply in November and December 2026, and many states restrict sale of intoxicating hemp products, so the legal interstate market for cannabinoid products is shrinking.
Can an out-of-state buyer own a cannabis licence?
In most states, yes, subject to background checks and disclosure. A few states still impose residency requirements, and courts disagree on whether those are constitutional. Ownership crossing state lines is a different question from product crossing state lines. Money and equity can generally move; marijuana cannot.
Should a cultivator in an oversupplied state wait for interstate commerce before selling?
That is a bet on federal action with no timetable. The trigger laws have sat unused since 2019, and the only state-level route, in California, was closed by the Attorney General's 2023 opinion. Carrying costs and price compression continue in the meantime. Most advisers would treat interstate sales as possible upside, not a plan.
Sources
- LegiScan — California SB 1326 (2022), chaptered text — https://legiscan.com/CA/text/SB1326/id/2605287
- Harris Sliwoski — California Inches Towards Interstate Cannabis Agreements (1 February 2023) — https://harris-sliwoski.com/cannalawblog/california-inches-towards-interstate-cannabis-agreements/
- Marijuana Moment — Interstate Marijuana Commerce Could Put California At Significant Legal Risk, Attorney General Says (December 2023) — https://www.marijuanamoment.net/interstate-marijuana-commerce-could-put-california-at-significant-legal-risk-of-federal-action-attorney-general-says/
- Washington State Legislature — SB 5069 bill summary (2023) — https://app.leg.wa.gov/billsummary?billnumber=5069&year=2023
- Justia — Northeast Patients Group v. United Cannabis Patients and Caregivers of Maine, No. 21-1719 (1st Cir. 17 August 2022) — https://law.justia.com/cases/federal/appellate-courts/ca1/21-1719/21-1719-2022-08-17.html
- Vicente LLP — Variscite Ruling: Residency Requirements and the Future of Intrastate Cannabis Markets — https://vicentellp.com/insights/variscite-ruling-residency-requirements-and-the-future-of-intrastate-cannabis-markets/
- U.S. Court of Appeals, Ninth Circuit — Peridot Tree WA, Inc. v. Washington State Liquor and Cannabis Control Board, No. 24-3481 (2 January 2026) — https://cdn.ca9.uscourts.gov/datastore/opinions/2026/01/02/24-3481.pdf
- Supreme Court of the United States — Docket No. 26-343, Peridot Tree WA, Inc., et al. v. Washington State Liquor and Cannabis Board, et al. (petition filed 10 Sep 2026) — https://www.supremecourt.gov/search.aspx?filename=/docket/docketfiles/html/public/26-343.html
- Oregon Legislature (OLIS) — SB 582, 2019 Regular Session, enrolled text — https://olis.oregonlegislature.gov/liz/2019R1/Downloads/MeasureDocument/SB582/Enrolled
- U.S. Court of Appeals, Fourth Circuit — Jensen v. Maryland Cannabis Administration, No. 24-1216 (2 September 2025) — https://www.ca4.uscourts.gov/opinions/241216.P.pdf
- Duane Morris — Can States Favor Local Cannabis Businesses? The Supreme Court Declines to Resolve (29 July 2026) — https://blogs.duanemorris.com/cannabis/2026/07/29/can-states-favor-local-cannabis-businesses-the-supreme-court-declines-to-resolve/
- Harris Sliwoski — Dormant Commerce Clause Meets Cannabis (13 January 2026) — https://harris-sliwoski.com/cannalawblog/dormant-commerce-clause-meets-cannabis-residency-requirements-federal-illegality-and-what-comes-next/
- Federal Register — Rescheduling of FDA-Approved Products and State-Licensed Medical Marijuana (28 April 2026) — https://www.federalregister.gov/d/2026-08176